Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Net LoansDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nomura Holdings (NMR) Gains from Sales and Divestitures (2016 - 2026)

Nomura Holdings has reported Gains from Sales and Divestitures over the past 18 years, most recently at $3.8 billion for Q1 2026.

  • For Q1 2026, Gains from Sales and Divestitures fell 2.72% year-over-year to $3.8 billion; the TTM value through Mar 2026 reached $3.8 billion, down 2.72%, while the annual FY2026 figure was $3.8 billion, 2.72% down from the prior year.
  • Gains from Sales and Divestitures for Q1 2026 was $3.8 billion at Nomura Holdings, down from $3.9 billion in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $4.6 billion in Q2 2022 and troughed at $3.8 billion in Q1 2026.
  • A 5-year average of $4.1 billion and a median of $4.0 billion in 2023 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: fell 20.29% in 2022 and later increased 7.58% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $4.2 billion in 2022, then decreased by 4.42% to $4.0 billion in 2023, then decreased by 2.77% to $3.9 billion in 2024, then fell by 1.21% to $3.9 billion in 2025, then fell by 1.87% to $3.8 billion in 2026.
  • Business Quant data shows Gains from Sales and Divestitures for NMR at $3.8 billion in Q1 2026, $3.9 billion in Q4 2025, and $4.0 billion in Q3 2025.